While Fortrea demonstrated revenue growth, positive cash flow, and technological innovation, the decline in new business wins and a significant goodwill impairment charge pose challenges. The company remains optimistic about future growth and operational improvements.

Company Guidance -

Q3 2025

During the Fortrea Second Quarter 2025 Earnings Conference Call, the company provided updated guidance for the fiscal year. Fortrea reported revenue of $710.3 million for the second quarter, with an adjusted EBITDA of $54.9 million. The company's backlog as of June 30, 2025, stood at $7.5 billion, with a book-to-bill ratio of 0.79x for the quarter and 1.1x for the trailing 12 months. Fortrea increased its revenue guidance for the year to a range of $2.6 billion to $2.7 billion while reaffirming its adjusted EBITDA range of $170 million to $200 million. The company highlighted operational improvements, including achieving one-third of its $150 million gross savings target in the first half of the year. Additionally, Fortrea experienced positive cash flow for the quarter, with expectations of generating positive cash flow in the remaining quarters of 2025. The company also mentioned a strong demand for its clinical pharmacology services and ongoing investment in innovation, such as the introduction of new modules in its Accelerate software platform.

Revenue Growth

Fortrea reported second-quarter revenue of $710.3 million, reflecting a 7.2% increase compared to the prior year.

Adjusted EBITDA Performance

Adjusted EBITDA stood at $54.9 million, demonstrating sequential improvement supported by margin optimization initiatives.

Positive Cash Flow

The company generated positive operating cash flow of $21.8 million in the second quarter.

Clinical Pharmacology Success

The Clinical Pharmacology Services unit continues to perform well, delivering a bioequivalence trial ahead of schedule.

Innovation in Technology

Introduction of three new modules in the Accelerate software platform, including Risk Radar, which enhances risk-based quality management in clinical trials.

Fortrea Holdings Inc. (FTRE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

FTRE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 17, 2025	2025 (Q3)	0.15 / -	0.23	―	―	―
Aug 06, 2025	2025 (Q2)	0.08 / 0.19	-0.03	733.33% (+0.22)
May 12, 2025	2025 (Q1)	-0.05 / 0.02	-0.04	150.00% (+0.06)
Mar 03, 2025	2024 (Q4)	0.36 / 0.18	0.19	-5.26% (-0.01)
Nov 08, 2024	2024 (Q3)	0.25 / 0.23	0.24	-4.17% (>-0.01)
Aug 12, 2024	2024 (Q2)	0.07 / -0.03	0.52	-105.77% (-0.55)
May 13, 2024	2024 (Q1)	<0.01 / -0.04	0.454	-108.81% (-0.49)
Mar 11, 2024	2023 (Q4)	0.23 / 0.19	―	―
Nov 13, 2023	2023 (Q3)	0.16 / 0.24	0.682	-64.81% (-0.44)	―
Aug 14, 2023	2023 (Q2)	0.39 / 0.52	0.748	-30.48% (-0.23)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

FTRE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$6.56	$6.58	+0.30%
May 12, 2025	$6.15	$5.19	-15.61%
Mar 03, 2025	$13.85	$10.38	-25.05%
Nov 08, 2024	$18.05	$23.50	+30.19%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Fortrea Holdings Inc. (FTRE) report earnings?

Fortrea Holdings Inc. (FTRE) is schdueled to report earning on Nov 17, 2025, Before Open (Confirmed).

What is Fortrea Holdings Inc. (FTRE) earnings time?

Fortrea Holdings Inc. (FTRE) earnings time is at Nov 17, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is FTRE EPS forecast?

FTRE EPS forecast for the fiscal quarter 2025 (Q3) is 0.15.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing